ReviewFrontiers in oncology2023
Desmoglein-2 as a cancer modulator: friend or foe?
Kay K Myo Min et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ReviewFrontiers in oncology2023
Kay K Myo Min et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.